Bt7455, a fully synthetic bicycle tumortargeted immune cell agonist((r)), leads to potent epha2-dependent cd137 agonism and robust anti-tumor efficacy
Kristen Hurov,Lia Luus,Johanna Lahdenranta,Punit Upadhyaya,Heather Cohen, Chinmayee Shah,Julia Kristensson,Peter Brown,Gemma Mudd,Carly Campbell,Elizabeth Repash,Eric Haines,Sailaja Battula,Mike Kelly,Phil Jeffrey,Paul Beswick,Liuhong Chen,Kevin McDonnell,Philip Brandish,Nicholas Keen JOURNAL FOR IMMUNOTHERAPY OF CANCER（2022）
AI 理解论文
溯源树
样例
